Tender detail
Open-house medicine discount agreements for levothyroxine sodium (ATC H03AA01)
Summary
The procurement concerns non-exclusive discount agreements for medicines containing the active substance levothyroxine sodium (ATC H03AA01), under an open-house model that allows agreements to be concluded at any time from 1 January 2027 to 31 December 2028. Medicines listed as paediatric medicines under the relevant German federal medicines list are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.